About Us
Our Pipeline and Technology
Newsroom
Contact Us
More
May 1, 2023
NexEos Bio Names Dawn Rubel as President, Research and Development
March 28, 2023
Pivot Center: University of Utah researcher, Dr. Gerald Gleich of NexEos Bio recognized for decades-long career studying eosinophils
April 10, 2020
FDA Grants Orphan Drug Designation to NexEos Bio’s Investigational Radioimaging Agent as a Diagnostic for the Management of Eosinophilic Esophagitis
August 9, 2019
NexEos licenses novel University of Utah imaging tech for diagnosing eosinophil-related inflammation